Pharmaceutical major Wockhardt Ltd. is going to shift its focus to drug discovery and biologics after exiting the US generics ...

A new study published in Cell has unveiled a first-of-a-kind optogenetic screening platform, developed by scientists at Integrated Biosciences, a biotechnology company integrating optogenetics, ...

Prof. Hening Lin brings expertise in enzymes to UChicago, bridging scientists, engineers and doctors to translate research to ...

"Synthetic biology tools like optogenetics allow us to precisely tune complex cellular processes, something traditional drug screening cannot do," said Maxwell Wilson, Ph.D., Co-Founder and Chief ...

A novel optogenetic screening platform enables a high-throughput screen and identified several integrated stress response-potentiating compounds.

Molecular glues, tiny molecules that connect one protein to another, are promising targets for pharmaceutical research. By ...

The analysis reveals a strong dominance of AI applications in oncology, comprising 72.8% of all included studies. This skew ...

Justice Department worker faces capital murder charge after allegedly giving abortion drug to his pregnant girlfriend without her consent, leading to the loss of her fetus.

Over the past year, drug discovery has gotten a massive boost from the CAS BioFinder Discovery Platform, which allows scientists to explore known and predicted data that accelerate the preclinical ...

Phenotypic screening has re-emerged as a powerful strategy for identifying drugs based on their observable effects. Discover how phenotypic screening accelerates drug discovery, supports drug ...